Joshua Mayourian1, Delaine K Ceholski1, Przemek A Gorski1, Prabhu Mathiyalagan1, Jack F Murphy1, Sophia I Salazar1, Francesca Stillitano1, Joshua M Hare1, Susmita Sahoo1, Roger J Hajjar1, Kevin D Costa2. 1. From the Cardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (J.M., D.K.C., P.A.G., P.M., J.F.M., S.I.S., F.S., S.S., R.J.H., K.D.C.); and Interdisciplinary Stem Cell Institute, Department of Cardiology, University of Miami Miller School of Medicine, Miami, FL (J.M.H.). 2. From the Cardiovascular Research Center, Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (J.M., D.K.C., P.A.G., P.M., J.F.M., S.I.S., F.S., S.S., R.J.H., K.D.C.); and Interdisciplinary Stem Cell Institute, Department of Cardiology, University of Miami Miller School of Medicine, Miami, FL (J.M.H.). kevin.costa@mssm.edu.
Abstract
RATIONALE: The promising clinical benefits of delivering human mesenchymal stem cells (hMSCs) for treating heart disease warrant a better understanding of underlying mechanisms of action. hMSC exosomes increase myocardial contractility; however, the exosomal cargo responsible for these effects remains unresolved. OBJECTIVE: This study aims to identify lead cardioactive hMSC exosomal microRNAs to provide a mechanistic basis for optimizing future stem cell-based cardiotherapies. METHODS AND RESULTS: Integrating systems biology and human engineered cardiac tissue (hECT) technologies, partial least squares regression analysis of exosomal microRNA profiling data predicted microRNA-21-5p (miR-21-5p) levels positively correlate with contractile force and calcium handling gene expression responses in hECTs treated with conditioned media from multiple cell types. Furthermore, miR-21-5p levels were significantly elevated in hECTs treated with the exosome-enriched fraction of the hMSC secretome (hMSC-exo) versus untreated controls. This motivated experimentally testing the human-specific role of miR-21-5p in hMSC-exo-mediated increases of cardiac tissue contractility. Treating hECTs with miR-21-5p alone was sufficient to recapitulate effects observed with hMSC-exo on hECT developed force and expression of associated calcium handling genes (eg, SERCA2a and L-type calcium channel). Conversely, knockdown of miR-21-5p in hMSCs significantly diminished exosomal procontractile and associated calcium handling gene expression effects on hECTs. Western blots supported miR-21-5p effects on calcium handling gene expression at the protein level, corresponding to significantly increased calcium transient amplitude and decreased decay time constant in comparison to miR-scramble control. Mechanistically, cotreating with miR-21-5p and LY294002, a PI3K inhibitor, suppressed these effects. Finally, mathematical simulations predicted the translational capacity for miR-21-5p treatment to restore calcium handling in mature ischemic adult human cardiomyocytes. CONCLUSIONS: miR-21-5p plays a key role in hMSC-exo-mediated effects on cardiac contractility and calcium handling, likely via PI3K signaling. These findings may open new avenues of research to harness the role of miR-21-5p in optimizing future stem cell-based cardiotherapies.
RATIONALE: The promising clinical benefits of delivering human mesenchymal stem cells (hMSCs) for treating heart disease warrant a better understanding of underlying mechanisms of action. hMSC exosomes increase myocardial contractility; however, the exosomal cargo responsible for these effects remains unresolved. OBJECTIVE: This study aims to identify lead cardioactive hMSC exosomal microRNAs to provide a mechanistic basis for optimizing future stem cell-based cardiotherapies. METHODS AND RESULTS: Integrating systems biology and human engineered cardiac tissue (hECT) technologies, partial least squares regression analysis of exosomal microRNA profiling data predicted microRNA-21-5p (miR-21-5p) levels positively correlate with contractile force and calcium handling gene expression responses in hECTs treated with conditioned media from multiple cell types. Furthermore, miR-21-5p levels were significantly elevated in hECTs treated with the exosome-enriched fraction of the hMSC secretome (hMSC-exo) versus untreated controls. This motivated experimentally testing the human-specific role of miR-21-5p in hMSC-exo-mediated increases of cardiac tissue contractility. Treating hECTs with miR-21-5p alone was sufficient to recapitulate effects observed with hMSC-exo on hECT developed force and expression of associated calcium handling genes (eg, SERCA2a and L-type calcium channel). Conversely, knockdown of miR-21-5p in hMSCs significantly diminished exosomal procontractile and associated calcium handling gene expression effects on hECTs. Western blots supported miR-21-5p effects on calcium handling gene expression at the protein level, corresponding to significantly increased calcium transient amplitude and decreased decay time constant in comparison to miR-scramble control. Mechanistically, cotreating with miR-21-5p and LY294002, a PI3K inhibitor, suppressed these effects. Finally, mathematical simulations predicted the translational capacity for miR-21-5p treatment to restore calcium handling in mature ischemic adult human cardiomyocytes. CONCLUSIONS:miR-21-5p plays a key role in hMSC-exo-mediated effects on cardiac contractility and calcium handling, likely via PI3K signaling. These findings may open new avenues of research to harness the role of miR-21-5p in optimizing future stem cell-based cardiotherapies.
Authors: Joshua Mayourian; Delaine K Ceholski; David M Gonzalez; Timothy J Cashman; Susmita Sahoo; Roger J Hajjar; Kevin D Costa Journal: Circ Res Date: 2018-01-05 Impact factor: 17.367
Authors: Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim Journal: Stem Cell Res Date: 2010-01-04 Impact factor: 2.020
Authors: Joshua M Hare; Darcy L DiFede; Angela C Rieger; Victoria Florea; Ana M Landin; Jill El-Khorazaty; Aisha Khan; Muzammil Mushtaq; Maureen H Lowery; John J Byrnes; Robert C Hendel; Mauricio G Cohen; Carlos E Alfonso; Krystalenia Valasaki; Marietsy V Pujol; Samuel Golpanian; Eduard Ghersin; Joel E Fishman; Pradip Pattany; Samirah A Gomes; Cindy Delgado; Roberto Miki; Fouad Abuzeid; Mayra Vidro-Casiano; Courtney Premer; Audrey Medina; Valeria Porras; Konstantinos E Hatzistergos; Erica Anderson; Adam Mendizabal; Raul Mitrani; Alan W Heldman Journal: J Am Coll Cardiol Date: 2016-11-14 Impact factor: 24.094
Authors: Shigang Qiao; Jessica M Olson; Mark Paterson; Yasheng Yan; Ivan Zaja; Yanan Liu; Matthias L Riess; Judy R Kersten; Mingyu Liang; David C Warltier; Zeljko J Bosnjak; Zhi-Dong Ge Journal: Anesthesiology Date: 2015-10 Impact factor: 7.892
Authors: James E Cartledge; Christopher Kane; Priyanthi Dias; Meron Tesfom; Lucy Clarke; Benjamin Mckee; Samha Al Ayoubi; Adrian Chester; Magdi H Yacoub; Patrizia Camelliti; Cesare M Terracciano Journal: Cardiovasc Res Date: 2015-01-05 Impact factor: 10.787
Authors: Delaine K Ceholski; Irene C Turnbull; Venu Pothula; Laura Lecce; Andrew A Jarrah; Changwon Kho; Ahyoung Lee; Lahouaria Hadri; Kevin D Costa; Roger J Hajjar; Sima T Tarzami Journal: Stem Cell Res Date: 2017-07-08 Impact factor: 2.020
Authors: Donald G Phinney; Michelangelo Di Giuseppe; Joel Njah; Ernest Sala; Sruti Shiva; Claudette M St Croix; Donna B Stolz; Simon C Watkins; Y Peter Di; George D Leikauf; Jay Kolls; David W H Riches; Giuseppe Deiuliis; Naftali Kaminski; Siddaraju V Boregowda; David H McKenna; Luis A Ortiz Journal: Nat Commun Date: 2015-10-07 Impact factor: 14.919
Authors: William T Budd; Sarah J Seashols-Williams; Gene C Clark; Danielle Weaver; Valerie Calvert; Emanuel Petricoin; Ema A Dragoescu; Katherine O'Hanlon; Zendra E Zehner Journal: PLoS One Date: 2015-11-06 Impact factor: 3.240
Authors: Marcin Wysoczynski; Asif Pathan; Joseph B Moore; Talha Farid; Jae Kim; Marjan Nasr; Yi Kang; Hong Li; Roberto Bolli Journal: Stem Cell Rev Rep Date: 2019-08 Impact factor: 5.739
Authors: Delaine K Ceholski; Irene C Turnbull; Chi-Wing Kong; Simon Koplev; Joshua Mayourian; Przemek A Gorski; Francesca Stillitano; Angelos A Skodras; Mathieu Nonnenmacher; Ninette Cohen; Johan L M Björkegren; Daniel R Stroik; Razvan L Cornea; David D Thomas; Ronald A Li; Kevin D Costa; Roger J Hajjar Journal: J Mol Cell Cardiol Date: 2018-05-09 Impact factor: 5.000
Authors: Joseph B Moore; Xian-Liang Tang; John Zhao; Annalara G Fischer; Wen-Jian Wu; Shizuka Uchida; Anna M Gumpert; Heather Stowers; Marcin Wysoczynski; Roberto Bolli Journal: Basic Res Cardiol Date: 2018-11-16 Impact factor: 17.165
Authors: Moran Yadid; Johan U Lind; Herdeline Ann M Ardoña; Sean P Sheehy; Lauren E Dickinson; Feyisayo Eweje; Maartje M C Bastings; Benjamin Pope; Blakely B O'Connor; Juerg R Straubhaar; Bogdan Budnik; Andre G Kleber; Kevin Kit Parker Journal: Sci Transl Med Date: 2020-10-14 Impact factor: 17.956